Susquehanna International Group, LLP Biolife Solutions Inc Call Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$8.99 - $16.86 $112,375 - $210,750	12,500 New	12,500 $203,000
Q1 2023 May 16, 2023	SELL	$17.67 - $26.07 $302,157 - $445,797	-17,100 Reduced 53.77%	14,700 $319,000
Q4 2022 Feb 14, 2023	BUY	$16.95 - $25.07 $138,990 - $205,574	8,200 Added 34.75%	31,800 $578,000
Q3 2022 Nov 14, 2022	BUY	$14.64 - $26.7 $345,504 - $630,120	23,600 New	23,600 $537,000
Q2 2021 Aug 11, 2021	SELL	$29.51 - $44.62 $489,866 - $740,692	-16,600 Reduced 67.76%	7,900 $352,000
Q1 2021 May 17, 2021	SELL	$32.95 - $44.24 $678,770 - $911,344	-20,600 Reduced 45.68%	24,500 $882,000
Q4 2020 Feb 16, 2021	BUY	$27.5 - $45.75 $55,000 - $91,500	2,000 Added 4.64%	45,100 $1.8 Million
Q3 2020 Nov 16, 2020	BUY	$16.04 - $28.94 $498,844 - $900,034	31,100 Added 259.17%	43,100 $1.25 Million
Q2 2020 Aug 14, 2020	BUY	$9.2 - $17.06 $110,399 - $204,719	12,000 New	12,000 $196,000

188

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.12B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.